Mangalam Drugs and Organics vs Peers
- Market cap
- ₹50.65 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹23.04 – ₹43.20
Mangalam Drugs and Organics ranks 1st by market capitalisation among 1 Drug Manufacturers - Specialty & Generic companies tracked by ATS. Its largest peers are Mangalam Drugs & Organics. Its P/E of 22.5 compares with a peer median of 22.5.
Mangalam Drugs and Organics vs Drug Manufacturers - Specialty & Generic peers
Sorted by market capitalisation.
| Company | Close (₹) | 1D | Market cap (₹ cr) | P/E | P/B | ROE | 1Y return |
|---|---|---|---|---|---|---|---|
| Mangalam Drugs & Organics | 32.00 | -3.29% | 50.65 | 22.5 | 2.85 | 14.5% | +18.5% |
| Mangalam Drugs and Organics | 32.00 | -3.29% | 50.65 | 22.5 | 2.85 | 14.5% | +24.5% |
Source: NSE end-of-day prices; ratios from company filings. Data as of 9 October 2026. How this data is compiled.
Mangalam Drugs and Organics peer comparison — frequently asked questions
Who are Mangalam Drugs and Organics' competitors?
Mangalam Drugs and Organics' listed peers in Drug Manufacturers - Specialty & Generic include Mangalam Drugs & Organics, ranked here by market capitalisation.
How does Mangalam Drugs and Organics' P/E compare with its peers?
Mangalam Drugs and Organics trades at a P/E of 22.5, against a median of 22.5 across the 1 Drug Manufacturers - Specialty & Generic peers shown.
Which is the largest company among Mangalam Drugs and Organics' peers?
By market capitalisation, the largest company in the group is Mangalam Drugs & Organics at ₹50.65 crore, against ₹50.65 crore for Mangalam Drugs and Organics.
Same Data For Peers
Trade Mangalam Drugs and Organics With ATS
Track MANGALAM live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.